Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00010439 · ClinicalTrials.gov registry record · Phase 2
Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis
A Phase 2 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT00010439 is a Phase 2 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 10 participants.
The verdict
NCT00010439, a Phase 2 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
OBJECTIVES: I. Determine the effects of alendronate sodium on skeletal remodeling and bone mineral density of the hip and spine in children with high-turnover idiopathic juvenile osteoporosis.
Interventions
- DRUG Alendronate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2000-09 |
| Est. Completion | 2008-11 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00010439
The ClinicalTrials.gov registry entry for NCT00010439 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Alendronate is the first listed.
NCT00010439 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00010439 about?
NCT00010439 is a clinical study titled "Phase II Study of Alendronate Sodium in Children With High-Turnover Idiopathic Juvenile Osteoporosis". OBJECTIVES: I. Determine the effects of alendronate sodium on skeletal remodeling and bone mineral density of the hip and spine in children with high-turnover idiopathic juvenile osteoporosis.
What is the current status of trial NCT00010439?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2000-09. Estimated completion is 2008-11.
What interventions are being tested in trial NCT00010439?
The interventions under investigation include: Alendronate (DRUG).
Who is sponsoring clinical trial NCT00010439?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.